Titre : Procédures d'analyse sur micropuce

Procédures d'analyse sur micropuce : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunization Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Procédures d'analyse sur micropuce : Questions médicales les plus fréquentes", "headline": "Procédures d'analyse sur micropuce : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Procédures d'analyse sur micropuce : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-31", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Procédures d'analyse sur micropuce" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Techniques d'investigation", "url": "https://questionsmedicales.fr/mesh/D008919", "about": { "@type": "MedicalCondition", "name": "Techniques d'investigation", "code": { "@type": "MedicalCode", "code": "D008919", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Techniques d'analyse microfluidique", "alternateName": "Microfluidic Analytical Techniques", "url": "https://questionsmedicales.fr/mesh/D046210", "about": { "@type": "MedicalCondition", "name": "Techniques d'analyse microfluidique", "code": { "@type": "MedicalCode", "code": "D046210", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.588.465" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Électrophorèse sur puce", "alternateName": "Electrophoresis, Microchip", "url": "https://questionsmedicales.fr/mesh/D046209", "about": { "@type": "MedicalCondition", "name": "Électrophorèse sur puce", "code": { "@type": "MedicalCode", "code": "D046209", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.588.465.340" } } } ] }, { "@type": "MedicalWebPage", "name": "Analyse sur microréseau", "alternateName": "Microarray Analysis", "url": "https://questionsmedicales.fr/mesh/D046228", "about": { "@type": "MedicalCondition", "name": "Analyse sur microréseau", "code": { "@type": "MedicalCode", "code": "D046228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.588.570" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Analyse sur puce à tissus", "alternateName": "Tissue Array Analysis", "url": "https://questionsmedicales.fr/mesh/D046888", "about": { "@type": "MedicalCondition", "name": "Analyse sur puce à tissus", "code": { "@type": "MedicalCode", "code": "D046888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.588.570.850" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Procédures d'analyse sur micropuce", "alternateName": "Microchip Analytical Procedures", "code": { "@type": "MedicalCode", "code": "D046208", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tze Ping Loh", "url": "https://questionsmedicales.fr/author/Tze%20Ping%20Loh", "affiliation": { "@type": "Organization", "name": "Department of Laboratory Medicine, National University Hospital, Singapore. Electronic address: tploh@hotmail.com." } }, { "@type": "Person", "name": "Brian R Cooke", "url": "https://questionsmedicales.fr/author/Brian%20R%20Cooke", "affiliation": { "@type": "Organization", "name": "Department of Clinical Biochemistry, PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia." } }, { "@type": "Person", "name": "Thi Chi Mai Tran", "url": "https://questionsmedicales.fr/author/Thi%20Chi%20Mai%20Tran", "affiliation": { "@type": "Organization", "name": "Faculty of Medical Technology, Hanoi Medical University, Viet Nam; Department of Clinical Biochemistry, National Children's Hospital, Hanoi, Viet Nam." } }, { "@type": "Person", "name": "Corey Markus", "url": "https://questionsmedicales.fr/author/Corey%20Markus", "affiliation": { "@type": "Organization", "name": "Flinders University International Centre for Point-of-Care Testing, Flinders Health and Medical Research Institute, Adelaide, Australia." } }, { "@type": "Person", "name": "Rosita Zakaria", "url": "https://questionsmedicales.fr/author/Rosita%20Zakaria", "affiliation": { "@type": "Organization", "name": "RMIT University, School of Health and Biomedical Sciences, Melbourne, Victoria, Australia; Murdoch Children's Research Institute, Parkville, Victoria, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37099400", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2023.2194190" } }, { "@type": "ScholarlyArticle", "name": "Differential coverage for vaccines in the expanded program on immunization (EPI) among children in rural Pakistan.", "datePublished": "2023-03-16", "url": "https://questionsmedicales.fr/article/36933984", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2023.03.007" } }, { "@type": "ScholarlyArticle", "name": "A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia.", "datePublished": "2022-06-15", "url": "https://questionsmedicales.fr/article/35703731", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2022.2079305" } }, { "@type": "ScholarlyArticle", "name": "The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon's Expanded program on Immunization.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37957695", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12960-023-00869-7" } }, { "@type": "ScholarlyArticle", "name": "Analyzing the usage of theories of change for routine immunization programs -- a review of impact evaluations from LMICs.", "datePublished": "2024-09-09", "url": "https://questionsmedicales.fr/article/39252041", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s41043-024-00615-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Techniques d'investigation", "item": "https://questionsmedicales.fr/mesh/D008919" }, { "@type": "ListItem", "position": 3, "name": "Procédures d'analyse sur micropuce", "item": "https://questionsmedicales.fr/mesh/D046208" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Procédures d'analyse sur micropuce - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Procédures d'analyse sur micropuce", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Procédures d'analyse sur micropuce", "description": "Comment les micropuces aident-elles au diagnostic ?\nQuels types de maladies peuvent être diagnostiqués ?\nLes micropuces sont-elles fiables pour le diagnostic ?\nPeut-on utiliser les micropuces pour le dépistage précoce ?\nQuel est le rôle des micropuces en oncologie ?", "url": "https://questionsmedicales.fr/mesh/D046208?mesh_terms=Immunization+Programs&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Procédures d'analyse sur micropuce", "description": "Quels symptômes peuvent indiquer un besoin d'analyse sur micropuce ?\nLes résultats des micropuces révèlent-ils des symptômes ?\nLes micropuces peuvent-elles détecter des symptômes précoces ?\nPeut-on relier des symptômes à des profils génétiques ?\nLes symptômes varient-ils selon les résultats des micropuces ?", "url": "https://questionsmedicales.fr/mesh/D046208?mesh_terms=Immunization+Programs&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Procédures d'analyse sur micropuce", "description": "Les micropuces peuvent-elles aider à la prévention des maladies ?\nComment les résultats des micropuces influencent-ils la prévention ?\nPeut-on utiliser les micropuces pour la prévention des cancers ?\nLes micropuces aident-elles à la prévention des maladies infectieuses ?\nLes résultats des micropuces peuvent-ils influencer les vaccinations ?", "url": "https://questionsmedicales.fr/mesh/D046208?mesh_terms=Immunization+Programs&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Procédures d'analyse sur micropuce", "description": "Comment les micropuces influencent-elles les traitements ?\nLes micropuces peuvent-elles prédire la réponse au traitement ?\nQuels traitements peuvent être adaptés grâce aux micropuces ?\nLes micropuces aident-elles à éviter des effets secondaires ?\nPeut-on utiliser les micropuces pour le suivi des traitements ?", "url": "https://questionsmedicales.fr/mesh/D046208?mesh_terms=Immunization+Programs&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Procédures d'analyse sur micropuce", "description": "Quelles complications peuvent survenir avec les micropuces ?\nLes micropuces peuvent-elles causer des complications médicales ?\nComment minimiser les complications liées aux micropuces ?\nLes complications sont-elles fréquentes avec les micropuces ?\nLes résultats des micropuces peuvent-ils entraîner des complications psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D046208?mesh_terms=Immunization+Programs&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Procédures d'analyse sur micropuce", "description": "Quels facteurs de risque sont identifiés par les micropuces ?\nLes micropuces peuvent-elles évaluer le risque de maladies héréditaires ?\nComment les résultats des micropuces influencent-ils les facteurs de risque ?\nLes micropuces aident-elles à identifier des facteurs environnementaux ?\nPeut-on utiliser les micropuces pour le dépistage des facteurs de risque ?", "url": "https://questionsmedicales.fr/mesh/D046208?mesh_terms=Immunization+Programs&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les micropuces aident-elles au diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier des profils génétiques associés à des maladies." } }, { "@type": "Question", "name": "Quels types de maladies peuvent être diagnostiqués ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour le cancer, les maladies génétiques et infectieuses." } }, { "@type": "Question", "name": "Les micropuces sont-elles fiables pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles offrent une haute sensibilité et spécificité dans les résultats." } }, { "@type": "Question", "name": "Peut-on utiliser les micropuces pour le dépistage précoce ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont utiles pour le dépistage précoce de certaines pathologies." } }, { "@type": "Question", "name": "Quel est le rôle des micropuces en oncologie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à caractériser les tumeurs et à personnaliser les traitements." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un besoin d'analyse sur micropuce ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes persistants ou atypiques peuvent justifier une analyse." } }, { "@type": "Question", "name": "Les résultats des micropuces révèlent-ils des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent indiquer des prédispositions à des symptômes spécifiques." } }, { "@type": "Question", "name": "Les micropuces peuvent-elles détecter des symptômes précoces ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent identifier des marqueurs avant l'apparition des symptômes." } }, { "@type": "Question", "name": "Peut-on relier des symptômes à des profils génétiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains symptômes sont liés à des variations génétiques spécifiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les résultats des micropuces ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les résultats peuvent influencer la gravité et la nature des symptômes." } }, { "@type": "Question", "name": "Les micropuces peuvent-elles aider à la prévention des maladies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles identifient les risques génétiques et permettent des actions préventives." } }, { "@type": "Question", "name": "Comment les résultats des micropuces influencent-ils la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Ils guident les choix de mode de vie et de dépistage préventif." } }, { "@type": "Question", "name": "Peut-on utiliser les micropuces pour la prévention des cancers ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles aident à identifier les individus à risque élevé de cancer." } }, { "@type": "Question", "name": "Les micropuces aident-elles à la prévention des maladies infectieuses ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent identifier des susceptibilités génétiques aux infections." } }, { "@type": "Question", "name": "Les résultats des micropuces peuvent-ils influencer les vaccinations ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent guider les recommandations de vaccination selon le risque." } }, { "@type": "Question", "name": "Comment les micropuces influencent-elles les traitements ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent de personnaliser les traitements en fonction du profil génétique." } }, { "@type": "Question", "name": "Les micropuces peuvent-elles prédire la réponse au traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles aident à anticiper l'efficacité des traitements pour chaque patient." } }, { "@type": "Question", "name": "Quels traitements peuvent être adaptés grâce aux micropuces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements en oncologie, cardiologie et maladies auto-immunes peuvent être adaptés." } }, { "@type": "Question", "name": "Les micropuces aident-elles à éviter des effets secondaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de choisir des traitements avec moins d'effets indésirables." } }, { "@type": "Question", "name": "Peut-on utiliser les micropuces pour le suivi des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de surveiller l'évolution de la réponse au traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les micropuces ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs d'interprétation des résultats peuvent mener à des complications." } }, { "@type": "Question", "name": "Les micropuces peuvent-elles causer des complications médicales ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne causent pas de complications, mais des erreurs d'analyse peuvent survenir." } }, { "@type": "Question", "name": "Comment minimiser les complications liées aux micropuces ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "En assurant une formation adéquate des professionnels et des contrôles de qualité." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes avec les micropuces ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares, mais une vigilance est nécessaire lors de l'interprétation." } }, { "@type": "Question", "name": "Les résultats des micropuces peuvent-ils entraîner des complications psychologiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des résultats inattendus peuvent causer de l'anxiété ou du stress." } }, { "@type": "Question", "name": "Quels facteurs de risque sont identifiés par les micropuces ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Elles identifient des variations génétiques associées à des maladies spécifiques." } }, { "@type": "Question", "name": "Les micropuces peuvent-elles évaluer le risque de maladies héréditaires ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont utiles pour évaluer le risque de maladies héréditaires." } }, { "@type": "Question", "name": "Comment les résultats des micropuces influencent-ils les facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Ils permettent d'adapter les stratégies de prévention en fonction des risques identifiés." } }, { "@type": "Question", "name": "Les micropuces aident-elles à identifier des facteurs environnementaux ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent révéler des interactions entre gènes et environnement." } }, { "@type": "Question", "name": "Peut-on utiliser les micropuces pour le dépistage des facteurs de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de dépister des facteurs de risque génétiques précoces." } } ] } ] }

Sources (10000 au total)

Differential coverage for vaccines in the expanded program on immunization (EPI) among children in rural Pakistan.

Pakistan has a well-established Expanded Program on Immunization (EPI) however vaccine-preventable diseases still account for high infant and child mortality rates. This study describes the differenti... From October 2014 to September 2018, we enrolled children younger than 2 years of age from the Matiari Demographic Surveillance System in Sindh, Pakistan. Socio-demographic and vaccination history wer... Of the 3140 enrolled children, 48.4 % received all EPI recommended vaccines. Only 21.2 % of these were age appropriate. Around 45.4 % of the children were partially vaccinated, and 6.2 % were unvaccin... Vaccine coverage was low among children in Matiari, Pakistan, and majority received delayed doses. Parents' education status and year of study enrollment was protective against vaccine dropout and del...

A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia.

In response to the substantial clinical and economic burden of diseases caused by... A Markov model that simulated the disease processes of invasive pneumococcal disease (IPD), pneumonia, and acute otitis media (AOM) over a newborn cohort lifetime was used to evaluate the cost-effecti... Vaccination with PHiD-CV or PCV13 was estimated to avert approximately 700 cases of IPD (200 meningitis, 500 bacteremia), and around 5,000 cases of all-cause pneumonia. However, PHiD-CV vaccination wa... PCVs are a cost-effective strategy to relieve the burden associated with diseases caused by...

The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon's Expanded program on Immunization.

Immunization is regarded as one of the most cost-effective public health interventions in global health. However, its cost-effectiveness depends greatly on the knowledge and skills of vaccinators. Wit... Through a descriptive cross-sectional design, we used structured questionnaires and observation guides to collect data from vaccination staff in health facilities that were selected by a multistage sa... Overall, we collected data from Expanded Program on Immunization focal staff in 265 health facilities across 68 health districts. Over half (53%) of the surveyed facilities were found in rural areas. ... This study suggests marked deficits in immunization knowledge among vaccination staff and exposes common attitudes and practices that could contribute to missed opportunities for vaccination and hinde...

Analyzing the usage of theories of change for routine immunization programs -- a review of impact evaluations from LMICs.

In this article we analyzed the extent of the usage of Theories of Change (TOCs) and causal pathways in the evaluation of immunization programs to identify the challenges to generating evidence on how... We analyzed the use of the TOC in impact evaluations (IEs) of immunization interventions published after 2010, and its associated articles. The review includes studies from Evidence Gap Map and Yale r... Our review included 47 large-scale and 45 small-to medium-scale interventions. Of the included studies, 19% used a TOC, 56% described a causal pathway or used a conceptual diagram with varying degrees... Future implementers and evaluators need to develop clear TOCs that are based on established theory and have clearly articulated the underlying assumptions. Large-scale health system strengthening init...

Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).

Rotavirus (RV) vaccination was included in the Finnish National immunization Program (NIP) in 2009. RotaTeq (RV5) has been used exclusively with a national average vaccination coverage rate (VCR) of >... We first describe the incidence of RVGE, viral gastroenteritis (VGE), and acute gastroenteritis (AGE) for all Finnish children born during 2008-2011. Children were stratified by the year of birth into... RVGE incidence decreased significantly soon after implementation of RV vaccination in the NIP. In vaccine-eligible cohorts, no clear peak incidence in the youngest age groups could be observed, and no... Incidence of RVGE has remained low in all age groups during the 10 years following introduction of RV vaccine in the Finnish NIP. Differences in RVGE incidence were observed in regions with high as co...

Comprehensive assessment of the implementation of maternal immunization programs in Italy: A national survey across maternity care units.

The authors aimed to assess the characteristics and integration of immunization services into the prenatal care provided by maternity care units (MCUs) in Italy.... A cross-sectional nationwide study using a web-based survey was conducted from June to August 2021. The study population consisted of 342 obstetricians/gynecologists (OB/GYNs), members of the Italian ... Overall, 112 of 342 MCUs completed the survey, for an overall response rate of 32.7%. Almost all MCUs (96.4%) provided vaccine information, but only 22% had an onsite vaccination clinic. Less than hal... Institutional barriers and lack of certain vaccine-related services offered during prenatal care in Italian MCUs might be responsible for many missed vaccination opportunities. Embedding maternal immu...

Country score tool to assess readiness and guide evidence generation of immunization programs in aging adults in Europe.

Delaying of policies for immunization of aging adults, low vaccine uptake, and the lack of supportive evidence at the national level could diminish the value in health and economics of such programs. ... The tool was developed in two phases. First, a modified Delphi process was used to construct the tool. The process included a literature review, stakeholder consultations, and a three-round Delphi stu... The review identified 16 tools and frameworks that formed the first version of our tool with 14 items. Eight experts were involved in the Delphi panel. Through three Delphi rounds, four items were add... Through a thorough and transparent process, a country score tool was developed helping to identify strengths, weaknesses, and evidential requirements for decision-making and implementation of immuniza...